Literature DB >> 15278559

Calcium entry blocker nicardipine inhibits sodium and inorganic phosphate reabsorption independent of renal circulation in dogs.

F Goto1, I Watanabe.   

Abstract

The effects of nicardipine on renal function were studied in anesthetized dogs. The changes in the tubular sodium (Na) and inorganic phosphate (PO(4)) reabsorption caused by the drug infusion into the renal artery without altered systemic and real circulation were especially evaluated. In dogs receiving a smaller dose of nicardipine (5 ng.kg(-1).min(-1)) into the left renal artery the blood pressure and renal circulation did not change, but urine volume and urinary Na and PO(4) excretion increased significantly. In dogs receiving a larger dose of nicardipine (50 ng.kg(-1).min(-1)) into the renal artery, renal plasma flow, urine volume and urinary Na and PO(4) excretion increased significantly, but creatinine clearance did not. The fractional distal Na reabsorption did not change with nicardipine infusion in either group. PO(4) reabsorption is considered to occur mainly in the proximal renal tubule, so its appearance in urine in increased quantities without the changes of systemic and renal circulation suggests proximal activity of the drug.

Entities:  

Year:  1992        PMID: 15278559     DOI: 10.1007/s0054020060153

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  19 in total

1.  Renal phosphate transport: inhomogeneity of local proximal transport rates and sodium dependence.

Authors:  K Baumann; C de Rouffignac; N Roinel; G Rumrich; K J Ullrich
Journal:  Pflugers Arch       Date:  1975       Impact factor: 3.657

Review 2.  Possible role of cytosolic calcium and Na-Ca exchange in regulation of transepithelial sodium transport.

Authors:  A Taylor; E E Windhager
Journal:  Am J Physiol       Date:  1979-06

Review 3.  Lithium clearance: a new method for determining proximal and distal tubular reabsorption of sodium and water.

Authors:  K Thomsen
Journal:  Nephron       Date:  1984       Impact factor: 2.847

4.  The effects of dopamine on renal excretion of sodium, phosphate and cyclic AMP in thyroparathyroidectomized dogs.

Authors:  F Goto
Journal:  Endocrinol Jpn       Date:  1979-12

5.  Transfection-mediated expression of a dominant cAMP-resistant phenotype in the opossum kidney (OK) cell line prevents parathyroid hormone-induced inhibition of Na-phosphate cotransport. A protein kinase-A-mediated event.

Authors:  J H Segal; A S Pollock
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

6.  Sodium, phosphate, glucose, bicarbonate, and alanine interactions in the isolated proximal convoluted tubule of the rabbit kidney.

Authors:  V W Dennis; P C Brazy
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

7.  [Nicardipine inhibits phosphate reabsorption regardless of glomerular filtration rate in hypertensive surgical patients].

Authors:  I Sudo
Journal:  Masui       Date:  1991-09

Review 8.  Effects of calcium entry blockers on renin-angiotensin-aldosterone system, renal function and hemodynamics, salt and water excretion and body fluid composition.

Authors:  J H Bauer; S Sunderrajan; G Reams
Journal:  Am J Cardiol       Date:  1985-12-06       Impact factor: 2.778

9.  Verapamil effect on renal function of normotensive and hypertensive rats.

Authors:  M MacLaughlin; M de Mello Aires; G Malnic
Journal:  Ren Physiol       Date:  1985

10.  Tetracaine, procaine and verapamil inhibition of fluid absorption in isolated perfused rabbit proximal convoluted tubules.

Authors:  J F Figueiredo; G T Conti; D Falkenstein; D Sigulem; O L Ramos
Journal:  Braz J Med Biol Res       Date:  1982-10       Impact factor: 2.590

View more
  1 in total

1.  Treatment of intraoperative hypertension with enflurane, nicardipine, or human atrial natriuretic peptide: haemodynamic and renal effects.

Authors:  F Goto; S Kato; I Sudo
Journal:  Can J Anaesth       Date:  1992-11       Impact factor: 5.063

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.